Eberle F - Search Results

1

Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity.

Peter M, Bode K, Lipford GB, Eberle F, Heeg K, Dalpke AH. Peter M, et al. Among authors: eberle f. Immunology. 2008 Jan;123(1):118-28. doi: 10.1111/j.1365-2567.2007.02718.x. Epub 2007 Oct 23. Immunology. 2008. PMID: 17961163 Free PMC article.

2

Modifications in small interfering RNA that separate immunostimulation from RNA interference.

Eberle F, Giessler K, Deck C, Heeg K, Peter M, Richert C, Dalpke AH. Eberle F, et al. J Immunol. 2008 Mar 1;180(5):3229-37. doi: 10.4049/jimmunol.180.5.3229. J Immunol. 2008. PMID: 18292547

3

Bacterial RNA is recognized by different sets of immunoreceptors.

Eberle F, Sirin M, Binder M, Dalpke AH. Eberle F, et al. Eur J Immunol. 2009 Sep;39(9):2537-47. doi: 10.1002/eji.200838978. Eur J Immunol. 2009. PMID: 19662634 Free article.

4

Identification of modifications in microbial, native tRNA that suppress immunostimulatory activity.

Gehrig S, Eberle ME, Botschen F, Rimbach K, Eberle F, Eigenbrod T, Kaiser S, Holmes WM, Erdmann VA, Sprinzl M, Bec G, Keith G, Dalpke AH, Helm M. Gehrig S, et al. Among authors: eberle f, eberle me. J Exp Med. 2012 Feb 13;209(2):225-33. doi: 10.1084/jem.20111044. Epub 2012 Feb 6. J Exp Med. 2012. PMID: 22312113 Free PMC article.

5

Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I).

Binder M, Eberle F, Seitz S, Mücke N, Hüber CM, Kiani N, Kaderali L, Lohmann V, Dalpke A, Bartenschlager R. Binder M, et al. Among authors: eberle f. J Biol Chem. 2011 Aug 5;286(31):27278-87. doi: 10.1074/jbc.M111.256974. Epub 2011 Jun 9. J Biol Chem. 2011. PMID: 21659521 Free PMC article.

6

Inactivation of LPS and RNase A on photocatalytically active surfaces.

Kurz J, Eberle F, Graumann T, Kaschel ME, Sähr A, Neumann F, Dalpke AH, Erdinger L. Kurz J, et al. Among authors: eberle f. Chemosphere. 2011 Aug;84(9):1188-93. doi: 10.1016/j.chemosphere.2011.06.048. Epub 2011 Jul 16. Chemosphere. 2011. PMID: 21762949

7

Surveillance of siRNA integrity by FRET imaging.

Järve A, Müller J, Kim IH, Rohr K, MacLean C, Fricker G, Massing U, Eberle F, Dalpke A, Fischer R, Trendelenburg MF, Helm M. Järve A, et al. Among authors: eberle f. Nucleic Acids Res. 2007;35(18):e124. doi: 10.1093/nar/gkm694. Epub 2007 Sep 22. Nucleic Acids Res. 2007. PMID: 17890733 Free PMC article.

8

Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.

Bender S, Reuter A, Eberle F, Einhorn E, Binder M, Bartenschlager R. Bender S, et al. Among authors: eberle f. PLoS Pathog. 2015 Nov 20;11(11):e1005264. doi: 10.1371/journal.ppat.1005264. eCollection 2015 Nov. PLoS Pathog. 2015. PMID: 26588843 Free PMC article.

9

Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond.

Vallazza B, Petri S, Poleganov MA, Eberle F, Kuhn AN, Sahin U. Vallazza B, et al. Among authors: eberle f. Wiley Interdiscip Rev RNA. 2015 Sep-Oct;6(5):471-99. doi: 10.1002/wrna.1288. Epub 2015 Jun 9. Wiley Interdiscip Rev RNA. 2015. PMID: 26061157 Review.

10

Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy.

Lautenschlaeger S, Dumke C, Exeli L, Hauswald H, Engenhart-Cabillic R, Eberle F. Lautenschlaeger S, et al. Among authors: eberle f. Strahlenther Onkol. 2023 Nov;199(11):982-991. doi: 10.1007/s00066-023-02106-5. Epub 2023 Jul 10. Strahlenther Onkol. 2023. PMID: 37428207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page